ERBB2 and breast cancer: Our analysis showed that IFI30 were specifically upregulated and this high expression predicted high RFS and OS (p < 0.05) in Her2-subtype breast cancer, while high IFI30 expression predicted low RFS and OS (p < 0.05) in all breast cancer.